MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia

被引:5
|
作者
Bonometti, Arturo [1 ]
Ferrario, Giuseppina [2 ]
Parafioriti, Antonina [3 ]
Giardino, Demostene [4 ]
Simonetti, Federico [5 ]
Ginori, Alessandro [6 ]
Passoni, Emanuela [7 ]
Berti, Emilio [7 ,8 ]
机构
[1] Univ Pavia, Dept Mol Med, IRCCS San Matteo Fdn, Unit Anat Pathol, Pavia, Italy
[2] Univ Pavia, Dept Mol Med, IRCCS San Matteo Fdn, Pavia, Italy
[3] ASST PINI CTO Ctr Specialist Ortoped Traumatol Ga, Dept Pathol, Milan, Italy
[4] Casa Cura San Camillo, Surg Pathol Unit, Forte Dei Marmi, Italy
[5] Unico Versilia Hosp, Dept Hematol, Camaiore, Italy
[6] Azienda USL Toscana Nord Ovest, Pathol Unit, Polyspecialist Ctr Monterosso, Carrara, Italy
[7] Osped Maggiore Policlin, Dept Dermatol, Fdn IRCCS Ca Granda, Milan, Italy
[8] Univ Milan, Dept Pathophysiol & Transplantat, IRCCS Fdn, Ca Granda Osped Maggiore Policlin, Milan, Italy
关键词
Langerhans cell histiocytosis; Rosai‐ Dorfman‐ Destombes disease; Erdheim‐ Chester disease; clonal relation; acute myeloid leukemia; MUTATIONS; LYMPHOMA;
D O I
10.1111/cup.13918
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mixed histiocytoses are a rare and recently recognized subset of histiocytic disorders that may involve the skin, characterized by the synchronous or metachronous development of lesions with Langerhans and/or non-Langerhans cell histiocytosis histopathological features. Around 10% of patients diagnosed with histiocytosis may develop a hematological malignancy, often with dramatic prognostic consequences. We hereby describe the exceptional case of a patient developing a MAP2K1-driven mixed histiocytosis with Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease, and Erdheim-Chester disease features and cutaneous involvement, progressing to a fatal and clonally-related acute myeloid leukemia. We reviewed the literature on similar cases and discussed the histopathological difficulties in their diagnosis and their clinical-pathological features.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 31 条
  • [1] Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders
    Papo, Matthias
    Cohen-Aubart, Fleur
    Trefond, Ludovic
    Bauvois, Adeline
    Amoura, Zahir
    Emile, Jean-Francois
    Haroche, Julien
    CURRENT ONCOLOGY REPORTS, 2019, 21 (07)
  • [2] Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim–Chester Disease, Destombes–Rosai–Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders
    Matthias Papo
    Fleur Cohen-Aubart
    Ludovic Trefond
    Adeline Bauvois
    Zahir Amoura
    Jean-François Emile
    Julien Haroche
    Current Oncology Reports, 2019, 21
  • [3] The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
    Jia‑wen Dai
    He Lin
    Long Chang
    Jian Li
    Dao-bin Zhou
    Xin-xin Cao
    Annals of Hematology, 2023, 102 : 3335 - 3343
  • [4] The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease
    Dai, Jia-wen
    Lin, He
    Chang, Long
    Li, Jian
    Zhou, Dao-bin
    Cao, Xin-xin
    ANNALS OF HEMATOLOGY, 2023, 102 (12) : 3335 - 3343
  • [5] Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis
    Salama, Hind Abdin
    Jazieh, Abdul Rahman
    Alhejazi, Ayman Yahya
    Absi, Ahmed
    Alshieban, Saeed
    Alzahrani, Mohsen
    Alaskar, Ahmed
    Gmati, Giamal
    Damlaj, Moussab
    Abuelgasim, Khadega A.
    Alghamdi, Abdulrahman
    Alahmari, Bader
    Almugairi, Areej
    Alzahrani, Hazza
    Bazarbachi, Ali
    Musa, M. O. H.
    Goyal, Gaurav
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : E66 - E75
  • [6] FDG PET/CT in Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease
    Ngo, Victoria T.
    Wassef, Heidi R.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (08) : 732 - 735
  • [7] Histology of Rosai-Dorfman disease in a subset of patients with Erdheim-Chester disease: A distinct entity mainly driven by MAP2K1.
    Razanamahery, Jerome
    Diamond, Eli L.
    Plate, Karlheinz
    Charlotte, Frederic
    Helias-Rodzewicz, Zofia
    Dogan, Ahmet
    Abdel-Wahab, Omar Ibrahim
    Durham, Benjamin Heath
    Ozkaya, Neval
    Amoura, Zahir
    Emile, Jean-Francois
    Haroche, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] HISTOLOGY OF ROSAI-DORFMAN DISEASE IN A SUBSET OF PATIENTS WITH ERDHEIM-CHESTER DISEASE: A DISTINCT ENTITY MAINLY DRIVEN BY MAP2K1
    Razanamahery, J.
    Diamond, E.
    Cohen-Aubart, F.
    Karl-Heinz, P.
    Charlotte, F.
    Helias-Rodzewicz, Z.
    Dogan, A.
    Abdel-Wahab, O.
    Durham, B.
    Ozkaya, N.
    Amoura, Z.
    Emile, J-F.
    Haroche, J.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S37 - S38
  • [9] Erdheim-Chester disease and Rosai-Dorfman disease. Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis
    Boesmueller, H.
    Nann, D.
    Horger, M.
    Fend, F.
    PATHOLOGE, 2015, 36 (05): : 458 - 465
  • [10] HISTOLOGY OF ROSAI-DORFMAN DISEASE IN A SUBSET OF PATIENTS WITH ERDHEIM-CHESTER DISEASE: A DISTINCT ENTITY MAINLY DRIVEN BY MAP2K1
    Razanamahery, J.
    Diamond, E.
    Cohen-Aubart, F.
    Karl-Heinz, P.
    Charlotte, F.
    Helias-Rodzewicz, Z.
    Dogan, A.
    Abdel-Wahab, O.
    Durham, B.
    Ozkaya, N.
    Amoura, Z.
    Emiles, J. -F.
    Haroche, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1677 - 1677